Bellco Joins NorrDia: A New Chapter in Blood Purification Begins

07 September 2026

We are proud to announce the successful completion of the acquisition of Mozarc’s Global Acute Adult and Chronic Businesses, including Bellco and Soludia.

Thanks to this acquisition, NorrDia further strengthens its market-leading position in blood purification therapies, bringing together complementary technologies, clinical expertise, and talented teams in blood purification.

Leo Ling, CEO of NorrDia: “Today marks a pivotal milestone for our organization as we welcome Bellco’s talented teams, dedicated partners, and global customer base to the NorrDia family.”
Together, we are expanding our ability to deliver comprehensive blood purification solutions, with one clear focus: improving care and outcomes for patients worldwide.

We look forward to this exciting new chapter and to shaping the future of blood purification therapies together with patients, customers and partners.